Bank of America
MRTX

Bank of America’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bank of America’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-36,000
Closed -$2.11M – 8389
2023
Q4 		$2.11M Sell
36,000
-352,165
-91% -$19.8M ﹤0.01% 4349
2023
Q3 		$16.9M Buy
388,165
+60,409
+18% +$2.16M ﹤0.01% 2213
2023
Q2 		$11.8M Sell
327,756
-58,494
-15% -$2.41M ﹤0.01% 2547
2023
Q1 		$14.4M Buy
386,250
+83,132
+27% +$3.74M ﹤0.01% 2456
2022
Q4 		$13.7M Buy
303,118
+42,229
+16% +$2.73M ﹤0.01% 2376
2022
Q3 		$18.2M Buy
260,889
+79,434
+44% +$5.88M ﹤0.01% 2056
2022
Q2 		$12.2M Buy
181,455
+1,911
+1% +$122K ﹤0.01% 2486
2022
Q1 		$14.8M Buy
179,544
+108,406
+152% +$11.1M ﹤0.01% 2460
2021
Q4 		$10.4M Sell
71,138
-45,855
-39% -$7.12M ﹤0.01% 2889
2021
Q3 		$20.7M Sell
116,993
-100,238
-46% -$16.1M ﹤0.01% 2148
2021
Q2 		$35.1M Buy
217,231
+68,852
+46% +$11.1M ﹤0.01% 1628
2021
Q1 		$25.4M Buy
148,379
+54,949
+59% +$10.9M ﹤0.01% 1831
2020
Q4 		$20.5M Sell
93,430
-4,653
-5% -$1.01M ﹤0.01% 1867
2020
Q3 		$16.3M Sell
98,083
-50,617
-34% -$6.93M ﹤0.01% 1878
2020
Q2 		$17M Sell
148,700
-381
-0.3% -$37K ﹤0.01% 1746
2020
Q1 		$11.5M Buy
149,081
+102,040
+217% +$9.15M ﹤0.01% 1955
2019
Q4 		$6.06M Sell
47,041
-41,305
-47% -$3.98M ﹤0.01% 3057
2019
Q3 		$6.88M Sell
88,346
-21,340
-19% -$2M ﹤0.01% 2890
2019
Q2 		$11.3M Buy
109,686
+12,490
+13% +$972K ﹤0.01% 2416
2019
Q1 		$7.13M Buy
97,196
+82,698
+570% +$5.63M ﹤0.01% 2810
2018
Q4 		$614K Sell
14,498
-1,820
-11% -$72.5K ﹤0.01% 4793
2018
Q3 		$768K Sell
16,318
-17,401
-52% -$969K ﹤0.01% 4659
2018
Q2 		$1.66M Buy
33,719
+30,880
+1,088% +$1.17M ﹤0.01% 4113
2018
Q1 		$87K Buy
2,839
+2,239
+373% +$62.2K ﹤0.01% 5794
2017
Q4 		$11K Sell
600
-2,100
-78% -$32.6K ﹤0.01% 6593
2017
Q3 		$32K Sell
2,700
-4,783
-64% -$27.7K ﹤0.01% 6114
2017
Q2 		$27K Sell
7,483
-1,065
-12% -$4.08K ﹤0.01% 6127
2017
Q1 		$44K Buy
8,548
+3,737
+78% +$20.5K ﹤0.01% 5982
2016
Q4 		$23K Buy
4,811
+1,217
+34% +$6.62K ﹤0.01% 6299
2016
Q3 		$24K Buy
3,594
+2,527
+237% +$13.4K ﹤0.01% 6060
2016
Q2 		$6K Buy
1,067
+1,052
+7,013% +$16.8K ﹤0.01% 6639
2016
Q1 		$0 Sell
15
-5,024
-100% -$112K ﹤0.01% 7411
2015
Q4 		$159K Buy
5,039
+268
+6% +$9.47K ﹤0.01% 5509
2015
Q3 		$164K Sell
4,771
-3,552
-43% -$107K ﹤0.01% 5439
2015
Q2 		$262K Buy
8,323
+8,301
+37,732% +$245K ﹤0.01% 5109
2015
Q1 		$1K Buy
+22
New +$516 ﹤0.01% 6882
2014
Q3 		– Sell
-5,479
Closed -$110K – 8223
2014
Q2 		$110K Buy
+5,479
New +$106K ﹤0.01% 6066

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of America's MRTX Position: Q1 2024 in Review

Bank of America sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 36,000 shares — an estimated $2.11M sold.

Bank of America first reported a position in MRTX in Q2 2014 and held it in 37 quarters. The position peaked at $35.1M in Q2 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Bank of America reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of America sold 36,000 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.11M.
  • Bank of America first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2014 and held it in 37 quarters.
  • Bank of America's Mirati Therapeutics, Inc. Common Stock position peaked at $35.1M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.